Brazilian Patent Issued for Lung & Colorectal Cancer
Filed with ASX · · 1 page · English
Story so far
Earlier from Inoviq
- Appendix 4C & Quarterly Activities Report
- AGM Presentation
- BARD1 Appoints New CSO
- BARD1 Share Purchase Plan Completed Oversubscribed
- Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test
Later from Inoviq
- Update on Legal Proceedings and BARD1 Autoantibody Program
- INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
- INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests
- IIQ Appendix 4C & Quarterly Activities Report - March 2022
- INOVIQ Key Manufacturing Agreement to Advance SubB2M tests
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq